Evidence map›Paper›PMID 41788963›Full record

ArticleJournal of education and health promotion2026

Population attributable fraction of associated factors to adherence to blood glucose self-monitoring in diabetic type 2 patients treated with insulin or sulfonylureas/meglitinides: The results of DiaCare study in Iran.

Amin Mohammadi, Gita Shafiee, Alireza Olyaeemanesh, Rajabali Daroudi, Amirhossein Aghakhani, Ensieh Nasli-Esfahani, Farideh Razi, Ramin Heshmat, Amirhossein Takian

Abstract read
In one paragraph

Article in Journal of education and health promotion, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Amin MohammadiDepartment of Health Policy, Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Gita ShafieeChronic Diseases Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Alireza OlyaeemaneshHealth Equity Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Rajabali DaroudiDepartment of Health Policy, Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Amirhossein AghakhaniEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Ensieh Nasli-EsfahaniDiabetes Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Farideh RaziMetabolomics and Genomics Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Ramin HeshmatChronic Diseases Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Amirhossein TakianDepartment of Health Policy, Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSelf-monitoring of blood glucose (SMBG) is a part of diabetes management. Numerous investigations have demonstrated inadequate adherence to SMBG. We investigated the level of adherence to SMBG in diabetic type 2 patients treated with insulin or sulfonylureas/meglitinide and the population attributable fraction of associated factors to SMBG in Iran. MATERIALS AND

methodsThis cross-sectional study used data from the population-based study on diabetes care in Iran (DiaCare). Overall, 13392 diabetic persons aged 35-75 years were recruited from urban/rural areas of all 31 provinces of Iran in the DiaCare study. Our samples in the current study consisted of 7,481 individuals who were administered insulin or oral medications required to undertake SMBG. The patients were divided into two groups: the adherence group was those who used insulin and were required to perform SMBG at least twice per day or those who relied on oral medications (sulfonylureas/meglitinides) who were expected to engage in SMBG at least twice a week. Patients who did not meet these requirements were categorized as the nonadherence group. Univariate comparisons and multivariate logistic regression were used to assess the relationships between SMBG adherence and related factors and to calculate the population attributable fraction (PAF); the complex survey design was taken into consideration.

resultsA total of 17.8% (1096/7481) of patients were seen to adhere to the SMBG. However, the rate of SMBG adherence was 38.8 percent in patients who used sulfonylureas/meglitinides; only 3.26% of patients on insulin were SMBG adherent. The adherence rates for men and women and also age groups were not statistically significant. The adherence rate in urban regions was 19.31%, while in rural areas, it was 11.51%. The multivariable analysis revealed that the probability of performing SMBG is much higher among married patients (OR = 1.84, 95% CI: 1.05,3.21). In addition, the factors of urbanization (OR = 1.79, 95% CI = 1.15-2.78), university education (OR = 1.99, 95% CI: 1.12, 3.55), and no smoking (OR = 1.78, 95% CI = 1.11,2.86) were also positively associated with the possibility of doing SMBG. Being married showed the highest PAF (PAF = 42.74%), followed by not smoking (PAF = 39.41%) and living in urban areas (PAF = 38.46%). Having an education higher than high school demonstrated the lowest PAF (PAF = 8.78%).

conclusionsMost patients did not adhere to the suggested practice of SMBG. Factors such as marriage, urbanization, university education, and no smoking were shown to be associated with adherence to SMBG with high PAF. We advocate further qualitative and exploratory research to examine the underlying causes of nonadherence to SMBG in Iran.

Indexed as

Blood glucose self-monitoringosediabetes mellitus type 2insulinIranmeglitinidesulfonylurea compoundstreatment adherence and compliance

Identifiers

PMID41788963
PMCPMC12959516

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.